Xavier Hébuterne

10.1k total citations · 2 hit papers
182 papers, 5.9k citations indexed

About

Xavier Hébuterne is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Xavier Hébuterne has authored 182 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Genetics, 59 papers in Epidemiology and 49 papers in Surgery. Recurrent topics in Xavier Hébuterne's work include Inflammatory Bowel Disease (64 papers), Microscopic Colitis (45 papers) and Clinical Nutrition and Gastroenterology (31 papers). Xavier Hébuterne is often cited by papers focused on Inflammatory Bowel Disease (64 papers), Microscopic Colitis (45 papers) and Clinical Nutrition and Gastroenterology (31 papers). Xavier Hébuterne collaborates with scholars based in France, United States and Belgium. Xavier Hébuterne's co-authors include S. Schneider, Jérôme Filippi, Paul Hofman, Željko Krznarić, Patrick Rampal, Alastair Forbes, Raanan Shamir, Stanisław Kłęk, Kalina Stardelova and Johanna C. Escher and has published in prestigious journals such as The Lancet, JAMA and Nature Genetics.

In The Last Decade

Xavier Hébuterne

166 papers receiving 5.7k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ESPEN guideline: Clinical nutrition in inflammatory bowel disease

2017 438 citations Xavier Hébuterne, S. Schneider et al. Clinical Nutrition profile →
ESPEN guideline on Clinical Nutrition in inflammatory bowel disease

2023 160 citations Xavier Hébuterne, S. Schneider et al. Clinical Nutrition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xavier Hébuterne France	44	2.0k	1.7k	1.6k	1.5k	1.2k	182	5.9k
Bernard Flourié France	52	3.1k 1.6×	2.4k 1.4×	1.7k 1.1×	1.2k 0.8×	2.2k 1.8×	219	8.0k
Alfred Gangl Austria	48	1.9k 0.9×	1.9k 1.1×	2.9k 1.9×	412 0.3×	847 0.7×	207	8.0k
Željko Krznarić Croatia	25	1.0k 0.5×	1.1k 0.6×	823 0.5×	2.0k 1.3×	948 0.8×	140	4.4k
Shigeki Bamba Japan	38	1.9k 0.9×	1.3k 0.7×	1.1k 0.7×	722 0.5×	395 0.3×	146	6.2k
John L. Rombeau United States	37	1.1k 0.5×	1.4k 0.8×	617 0.4×	1.5k 1.0×	2.1k 1.8×	114	5.1k
Johanna C. Escher Netherlands	40	4.0k 2.0×	2.2k 1.3×	2.7k 1.7×	453 0.3×	591 0.5×	164	6.9k
Tomoyuki Tsujikawa Japan	35	1.7k 0.9×	1.4k 0.8×	966 0.6×	395 0.3×	502 0.4×	145	5.3k
R. D’Incà Italy	49	3.6k 1.8×	2.1k 1.2×	2.5k 1.6×	375 0.3×	1.1k 0.9×	229	7.5k
Kristine H. Allin Denmark	34	1.1k 0.6×	972 0.6×	1.1k 0.7×	1.2k 0.8×	329 0.3×	123	5.4k
Claude Matuchansky France	33	875 0.4×	1.8k 1.1×	1.4k 0.9×	606 0.4×	1.3k 1.1×	136	5.0k

Countries citing papers authored by Xavier Hébuterne

Since Specialization

Citations

This map shows the geographic impact of Xavier Hébuterne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Hébuterne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Hébuterne more than expected).

Fields of papers citing papers by Xavier Hébuterne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Hébuterne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Hébuterne. The network helps show where Xavier Hébuterne may publish in the future.

Co-authorship network of co-authors of Xavier Hébuterne

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Hébuterne. A scholar is included among the top collaborators of Xavier Hébuterne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Hébuterne. Xavier Hébuterne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Panaccione, Remo, Silvio Danese, Wen Zhou, et al.. (2023). Efficacy and safety of upadacitinib for 16‐week extended induction and 52‐week maintenance therapy in patients with moderately to severely active ulcerative colitis. Alimentary Pharmacology & Therapeutics. 59(3). 393–408. 16 indexed citations

Fuméry, Mathurin, Stéphane Nancey, Jérôme Filippi, et al.. (2023). Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study. Alimentary Pharmacology & Therapeutics. 57(11). 1290–1298. 2 indexed citations

Panaccione, Remo, Silvio Danese, Aileen L. Pangan, et al.. (2022). A145 EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A RANDOMIZED PHASE 3 STUDY. Journal of the Canadian Association of Gastroenterology. 5(Supplement_1). 18–19. 3 indexed citations

Laharie, David, Stéphane Nancey, Xavier Hébuterne, et al.. (2020). Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease. Digestive and Liver Disease. 52(7). 740–744. 10 indexed citations

Reinisch, Walter, William J. Sandborn, Silvio Danese, et al.. (2019). DOP51 Biomarker and pharmacokinetic data from the TURANDOT II open-label extension study of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody SHP647 in patients with ulcerative colitis. Journal of Crohn s and Colitis. 13(Supplement_1). S058–S059. 2 indexed citations

Bonnaud, Guillaume, Jonathan Lévy, Philippe Cabarrot, et al.. (2016). Implementation of the French national consensus for the management of ulcerative colitis into clinical practice. Digestive and Liver Disease. 48(12). 1405–1409. 1 indexed citations

Peyrin‐Biroulet, Laurent, Yoram Bouhnik, Xavier Roblin, et al.. (2016). French national consensus clinical guidelines for the management of Crohn’s disease. Digestive and Liver Disease. 49(4). 368–377. 12 indexed citations

Gelsi, Ève, Damien Van Gysel, Anne-Claire Frin, et al.. (2016). Assessment of D-Dimers for the Early Prediction of Complications in Acute Pancreatitis. Pancreas. 45(7). 980–985. 18 indexed citations

D’Haens, Geert, Dino Tarabar, Édouard Louis, et al.. (2015). OP023. Methotrexate for corticosteroid-dependent ulcerative colitis: results of a placebo randomized controlled trial.. Journal of Crohn s and Colitis. 9(suppl 1). S14–S15. 1 indexed citations

10.

Bouguen, Guillaume, David Laharie, Stéphane Nancey, et al.. (2015). Efficacy and Safety of Adalimumab 80 mg Weekly in Luminal Crohnʼs Disease. Inflammatory Bowel Diseases. 21(5). 1047–1053. 13 indexed citations

11.

Vivinus-Nébot, Mylène, Hanene Bzioueche, Raffaella Dainese, et al.. (2013). Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 63(5). 744–752. 295 indexed citations

12.

Daperno, Marco, Fabiana Castiglione, Lissy de Ridder, et al.. (2011). Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 5(5). 484–498. 88 indexed citations

13.

Yandza, T., S. Schneider, Seigo Nishida, et al.. (2010). Outcome of Exfoliative Rejection After Isolated Intestinal Transplantation in an Adult: Case Report. Transplantation Proceedings. 42(1). 100–102. 2 indexed citations

14.

Oussalah, Abderrahim, Ludovic Evesque, David Laharie, et al.. (2010). A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization. The American Journal of Gastroenterology. 105(12). 2617–2625. 146 indexed citations

15.

Hébuterne, Xavier & S. Schneider. (2005). What Are the Goals of Nutritional Support?. PubMed. 10. 89–102. 5 indexed citations

16.

Filippi, Jérôme, S. Schneider, Rima Al-Jaouni, et al.. (2005). Muscle Performance in Patients With Crohnʼs Disease in Clinical Remission. Inflammatory Bowel Diseases. 11(3). 296–303. 75 indexed citations

17.

Hébuterne, Xavier & S. Schneider. (2001). Impact of enteral nutrition on gastrointestinal functions. Clinical Nutrition. 20. 57–61. 4 indexed citations

18.

Hébuterne, Xavier, et al.. (1998). [Which patients should have an endoscopic percutaneous gastrostomy?].. PubMed. 22(12). 1065–70. 5 indexed citations

19.

Hastier, P, et al.. (1994). [The value of mycobacteria serology in the diagnosis of tubercular hepatitis].. PubMed. 30(3). 93–6. 1 indexed citations

20.

Hébuterne, Xavier, et al.. (1991). [Acute rhabdomyolysis due to fenoverine].. PubMed. 15(11). 861–2. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact